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and well-characterized data set offered by the main Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial (INTERACT2) study, we assessed the association of hematoma shape (irregularity) and density (heterogeneity) on clinical outcomes at 90 days.
Methods
Patients
INTERACT2 was an international, multicenter, open, blinded end point, randomized controlled trial, as described in detail elsewhere. 8 Patients with spontaneous ICH within 6 hours of onset and elevated systolic blood pressure (150-220 mm Hg) were allocated to intensive (target systolic blood pressure<140 mm Hg within 1 hour and maintained for 7 days) or contemporaneous guideline-recommended (<180 mm Hg) blood pressure-lowering treatment. Patients were followed up for 90 days, and outcomes of separate and combined death and major disability were assessed by blinded observers according to the modified Rankin scale (mRS).
Procedures
Demographic and clinical characteristics were recorded at the time of enrollment. Computed tomographic (CT) images were analyzed centrally by 3 neurologists (C.D., S.S., and S.Z.), blinded to clinical data, using the MIStar software version 3.2 (Apollo Medical Imaging Technology, Melbourne, Australia). Irregularity of shape and heterogeneity in density were assessed by visual inspection and rated using the scale of Barras et al 4 on the axial slice, showing the largest area of hematoma. The density and shape scale ranges from 1 (most regular shape or most homogeneous density) to 5 (most irregular shape or most heterogeneous density). Each progressive category is defined by an extra lesion edge irregularity on the shape scale, or a degree of density variation on the density scale. Shape or density was defined as irregular or heterogeneous when the total rating was 3, 4, or 5 on the visual scale, and regular or homogenous when the rating was 1 or 2 ( Figure I in the online-only Data Supplement). Hematoma volume, location, and other imaging characteristics that might be associated with outcome were not remeasured in this study but derived from the previously published data set. 8, 9 For descriptive purposes, baseline volumes were divided into 3 groups labeled as small (0-10 mL), medium (10-25 mL), or large (>25 mL). Hematoma location was categorized as lobar, deep (caudate nucleus, thalamus, and putamen), cerebellar, or brain stem.
The primary outcome was similar to that of the main study: the proportion of patients with poor outcome, defined as death or major disability (mRS score of 3-5) at 90 days after randomization. Secondary outcomes were death and major disability considered separately.
Statistical Analysis
Baseline characteristics were summarized as mean (SD) or median (interquartile range) for continuous variables, and as number (%) for categorical variables. Two neurologists (S.S. and S.Z.) independently analyzed 50% of the scans each, and an independent neurologist (C.D.) checked 20% of the scans for assessment of intraclass correlation coefficients for the Barras scale. Binary logistic regression was used to evaluate the association of hematoma shape and density on death/major disability, death, and major disability, with adjustment for age, China region, systolic blood pressure, National Institutes of Health stroke scale (NIHSS) score, prior use of antithrombotics, time from onset to CT scan, location and volume of hematoma at baseline, intraventricular extension of the ICH, randomized treatment, and decision to withdraw active treatment. Associations between shape and density and a shift of scores across all levels of the mRS were also calculated using ordinal logistic regression models as a sensitivity analysis. A standard level of significance (P<0.05) was used, and the data are reported as odds ratios (ORs) and 95% confidence intervals (CIs). Analyses were performed using SAS software (version 9.3).
Results
A total of 2066 subjects were included in the present analysis after excluding 732 patients without suitable brain CT scan images (not available in a format compatible with MiStar, magnetic resonance imaging or poor quality imaging) to allow adequate assessment of hematoma shape and density (n=701) or without mRS scoring at 90 days (n=31). Included patients were as a group, more severe than excluded patients on the Glasgow coma scale (median 14, interquartile range 13-15 versus 14, 12-15; P=0.002), and more likely to have deep (83% versus 59%) and small hematomas (median volume: 10.7 mL, interquartile range: 5.6-18.7 versus 11.9, 6.3-23.6; P=0.001; Table I in the online-only Data Supplement).
Baseline Characteristics
The baseline characteristics of the group are shown in Table 1 . In summary, 946 (45.8%) patients had irregular hematomas and 781 (37.8%) had heterogeneous hematomas. In terms of inter-rater reliability for the Barras scale, the intraclass correlation coefficient for shape was good (0.71; 95% CI, 0.67-0.74) and for density was fair (0.57; 95% CI, 0.52-0.61), respectively.
When compared with those with regular hematomas, patients with irregular hematomas, were older, less likely to be in China, had a more severe neurological status, were less likely to be on antihypertensive drugs, had larger hematomas, were more likely to have a lobar hematoma, and less likely to have an infratentorial hematoma. Patients with heterogeneous hematomas, when compared with patients with homogeneous hematomas, were clinically more severe, had larger hematomas, were more likely to have lobar hematoma, and less likely to have intraventricular extension. Smaller hematomas are more likely to be regular and homogeneous, whereas larger hematomas are more likely to be irregular and heterogeneous ( (Figure) .
Association of Shape and Density With 90-Day Outcomes
Discussion
We have shown the importance of hematoma shape in predicting poor clinical outcome in ICH. Hematomas with an irregular shape were associated with both combined death and disability, and disability alone, at 90 days. Conversely, hematoma density was not associated with either of these outcomes.
The relationship between irregularity in shape of the hematoma and poor outcome has previously been shown to be associated with higher 30-day mortality in a study of 106 patients (P=0.006). 7 The proposed mechanism was that irregular-shaped hematomas had a higher risk of hematoma growth, which is known to be associated with poor outcome in patients with ICH. 10, 11 Although growth seems to be the logical link between irregularity and poor outcome, there might be other factors involved. It is well recognized that ICH is a dynamic phenomenon 3 and new bleeding occurring at the border of the hematoma could produce irregularity of shape. Irregular-shaped hematomas might also lead to more persisting inflammation around the lesion. The eruption of blood into the brain tissue produces an injury with 
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an inflammatory response involving blood components and leading to enzyme activation, mediator release, inflammatory cell migration, glial cell activation, brain tissue breakdown, and repair processes. 12, 13 New bleeding areas at the periphery of the hematoma could sustain this inflammation for a longer period of time and lead to worsening outcome in patients with irregular hematoma. Another possible mechanism is that irregularity could contribute to worsening perihematomal edema, a known predictor of poorer outcome.
14 It is also possible that irregular shape is a marker for the pressure within the hematoma. Lower intrahematoma pressures might be better constrained by white matter bundles producing ellipsoid hematomas, whereas higher intrahematoma pressures might produce more aggressive dissection of brain tissue, leading to both more disability and an irregular outline. This would also account for the association between irregularity and hematoma growth.
We found no relationship between heterogeneity in hematoma density and poor outcome. Variability in density relates to clot formation and sedimentation of cellular components in the plasma. This translates into the higher density of more recent ICH on brain CT scans, which attenuates while the ICH is evolving. 15 Logically, a heterogeneous pattern might be associated with continued or recurrent bleeding with a mixture of fresh blood and old hematoma in the ICH cavity. This could be associated with clinical progression after the initial presentation. Our inability to demonstrate an increase in disability might be because this assumption is valid but the grading of heterogeneity is much more subjective than that of irregularity and this is reflected in the poor values for interrater agreement on this parameter. It is possible that there is an outcome effect of variation of density but this was lost in the noise of our assessment technique. In the emergency department setting, the identification of highly irregularshaped hematoma as predictors of poor outcome might be a useful addition to risk stratification in the acute assessment of patients with ICH.
The strength of our analysis lies in the ability to derive innovative data from a large randomized control trial of participants from multiple cultural and ethnic origins, the rigorous collection of baseline and outcome data, and the centrally coordinated and performed CT analysis with the exclusion of poor quality imaging. There are limitations to the study that should be noted. First, the present analysis was Second, the clinical trial population is subject to selection bias-patients with normal presenting blood pressure and a high likelihood of death in the first 24 hours where excluded. Although the association findings for shape are strong, they might require external validation in a nonclinical trial population. Third, we do not have information on hematoma growth, which would be the logical link between irregularity and poor outcome. The hematoma growth substudy in INTERACT2 only included a limited number of patients, and none had an irregular hemorrhage: it may be that investigators were reluctant to repeat CT scanning in patients with indicators of poor prognosis. Thus, although suspected, hematoma growth could not be proven as a key link in the interaction between hematoma shape and outcome. Finally, as noted above, the scale used to assess density was prone to subjectivity and had only fair reproducibility as shown by the low interclass correlation coefficient between the raters. Density assessment should not be used alone in clinical practice and further investigations are required regarding the best method of rating density and as a prognostic marker in ICH. In summary, we have shown an independent relationship between hematoma shape and poor outcome at 90 days after the onset of ICH, with irregularity being linked to both disability and death as a composite, and disability alone. These results reinforce the importance of assessing hematoma characteristics in the context of clinical features for assessing prognosis in the planning therapeutic interventions in patients with acute ICH.
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